New auranofin analogs with antibacterial properties against Burkholderia clinical isolates
D. Maydaniuk, B. Wu, D. Truong, S. H. Liyanage, A. M. Hogan, Z. L. Yap, M. Yan, S. T. Cardona
This study identifies two auranofin analogs, MS-40S and MS-40, with antibacterial activity against Burkholderia clinical isolates, including B. cenocepacia, and low toxicity in model organisms.
bioRxiv · Sep 10, 2021Microbiology